Last update July 11, 2023
Limited compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
C17H38BrN / C19H42BrN is Cetrimide in Molecular formula.
Is written in other languages:C17H38BrN / C19H42BrN is also known as
C17H38BrN / C19H42BrN belongs to these groups or families:
Main tradenames from several countries containing C17H38BrN / C19H42BrN in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Cetrimide, cetrimonium bromide and Cetrimonium Chloride are quaternary ammoniacal disinfectants, cationic surfactants, with antiseptic properties. It is bactericidal and has been used to clean skin, wounds and burns. They are used as a solution and creams. Cetrimide is frequently combined with chlorhexidine.
Since the last update we have not found published data on its excretion in breastmilk.
If ingested, cetrimide and other quaternary ammonium compounds cause nausea and vomiting; highly concentrated solutions are irritating and can cause oropharyngeal and esophageal burns.
Five newborns had oral burns after accidental ingestion of a solution of chlorhexidine and cetrimide. The damage was attributed to the caustic effect of cetrimide. (Mucklow 1988)
Do not apply on the breasts to prevent the infant from ingesting it; if necessary, apply after one feeding and clean well with water before the next.